Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-13

Clinical Trial Update: Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT [Phase 1]

View source ↗

Summary

A Phase 1 randomized trial evaluating the safety/feasibility of a subgingival local drug delivery system using 2% bromelain gel with 0.2% chlorhexidine gel afte…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 0.2% Chlorhexidine gel (chlorhexidine)
  • 2% Bromelain gel (bromelain)

Snippet

Sponsor: Krishnadevaraya College of Dental Sciences & Hospital | Conditions: Periodontal Pocket | Phase 1 | Status: RECRUITING